# Medium Chain Triglycerides (MCT) and Whey Protein Isolate (WPI) for Type 2 Diabetes Patients (Combine)

> **NCT04905589** · NA · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 22 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** BetaQuik™
- **DIETARY_SUPPLEMENT:** WheyBasics
- **OTHER:** Iso-voluminous water

## Key facts

- **NCT ID:** NCT04905589
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-30
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04905589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04905589, "Medium Chain Triglycerides (MCT) and Whey Protein Isolate (WPI) for Type 2 Diabetes Patients (Combine)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04905589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*